Vasantha Srikantan

Title: Vasantha Srikantan: Innovator in Prostate Cancer Research

Introduction

Vasantha Srikantan is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of prostate cancer research, holding 2 patents that focus on innovative methods for detecting and treating this prevalent disease.

Latest Patents

His latest patents include the development of the prostate-specific gene, PCGEM1, and methods of using PCGEM1 to detect, treat, and prevent prostate cancer. This nucleic acid sequence exhibits prostate-specific expression and over-expression in tumor cells. The sequence and its fragments are instrumental in detecting, diagnosing, preventing, and treating prostate cancer and other prostate-related diseases. Additionally, the sequence is valuable for measuring hormone responsiveness in prostate cancer cells.

Career Highlights

Vasantha Srikantan is affiliated with the Henry M. Jackson Foundation for the Advancement of Military Medicine Inc. His work at this institution underscores his commitment to advancing medical research and improving patient outcomes in the field of oncology.

Collaborations

He collaborates with esteemed colleagues such as Shiv Srivastava and Judd W Moul, contributing to a dynamic research environment focused on innovative cancer therapies.

Conclusion

Vasantha Srikantan's work in prostate cancer research exemplifies the impact of innovative thinking in medicine. His patents and collaborations highlight the importance of scientific advancements in improving healthcare outcomes.